Dr. Cuauhtemoc Magana, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $134,795 | 22 | 99.9% |
| Food and Beverage | $76.89 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Agilent Technologies, Inc. | $134,850 | 23 | $0 (2023) |
| bioMerieux Inc | $21.89 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $15,786 | 20 | Agilent Technologies, Inc. ($15,764) |
| 2021 | $52,150 | 1 | Agilent Technologies, Inc. ($52,150) |
| 2020 | $36,388 | 1 | Agilent Technologies, Inc. ($36,388) |
| 2019 | $30,493 | 1 | Agilent Technologies, Inc. ($30,493) |
| 2018 | $55.00 | 1 | Agilent Technologies, Inc. ($55.00) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $568.75 | General |
| 12/30/2023 | Agilent Technologies, Inc. | PD-L1 IHC 28-8 PHARMDX (Device) | Consulting Fee | Cash or cash equivalent | $81.25 | General |
| Category: PD-1/PD-L1 inhibitors | ||||||
| 12/30/2023 | Agilent Technologies, Inc. | PD-L1 IHC 28-8 PHARMDX (Device) | Consulting Fee | Cash or cash equivalent | $81.25 | General |
| Category: PD-1/PD-L1 inhibitors | ||||||
| 12/30/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $81.25 | General |
| 10/30/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| 09/20/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,218.75 | General |
| 09/20/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $812.50 | General |
| 09/20/2023 | Agilent Technologies, Inc. | OMNIS (Device) | Consulting Fee | Cash or cash equivalent | $81.25 | General |
| Category: Immunohistochemistry (IHC) and in Situ Hybridization Platform | ||||||
| 08/30/2023 | Agilent Technologies, Inc. | PD-L1 IHC 28-8 PHARMDX (Device) | Consulting Fee | Cash or cash equivalent | $325.00 | General |
| Category: PD-1/PD-L1 inhibitors | ||||||
| 08/30/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $162.50 | General |
| 07/30/2023 | Agilent Technologies, Inc. | PD-L1 IHC 28-8 PHARMDX (Device) | Consulting Fee | Cash or cash equivalent | $325.00 | General |
| Category: PD-1/PD-L1 inhibitors | ||||||
| 07/30/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $243.75 | General |
| 06/30/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $81.25 | General |
| 05/30/2023 | Agilent Technologies, Inc. | PD-L1 IHC 28-8 PHARMDX (Device) | Consulting Fee | Cash or cash equivalent | $4,468.75 | General |
| Category: PD-1/PD-L1 inhibitors | ||||||
| 05/30/2023 | Agilent Technologies, Inc. | PD-L1 IHC 28-8 PHARMDX (Device) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: PD-1/PD-L1 inhibitors | ||||||
| 04/25/2023 | bioMerieux Inc | — | Food and Beverage | In-kind items and services | $21.89 | General |
| 03/30/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $138.75 | General |
| 03/30/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $92.50 | General |
| 02/28/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,618.75 | General |
| 01/30/2023 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $832.50 | General |
| 02/24/2021 | Agilent Technologies, Inc. | PD-L1 IHC 22C3 pharmDx (Device) | Consulting Fee | Cash or cash equivalent | $52,149.82 | General |
| Category: pharmDx | ||||||
| 04/14/2020 | Agilent Technologies, Inc. | PD-L1 IHC 22C3 (Device) | Consulting Fee | Cash or cash equivalent | $36,388.22 | General |
| Category: pharmDx | ||||||
| 02/04/2019 | Agilent Technologies, Inc. | — | Consulting Fee | Cash or cash equivalent | $30,493.00 | General |
| 10/17/2018 | Agilent Technologies, Inc. | PD-L1 (Device) | Food and Beverage | In-kind items and services | $55.00 | General |
| Category: pharmDx | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 94 | 201 | $32,280 | $5,226 |
| 2020 | 11 | 333 | 691 | $101,520 | $19,862 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2023 | 44 | 84 | $19,908 | $2,504 | 12.6% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2023 | 11 | 53 | $5,565 | $1,229 | 22.1% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2023 | 13 | 35 | $3,150 | $759.86 | 24.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2023 | 13 | 13 | $1,833 | $371.28 | 20.3% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2023 | 13 | 16 | $1,824 | $361.12 | 19.8% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2020 | 101 | 210 | $49,770 | $7,123 | 14.3% |
| 88341 | Special stained specimen slides to examine tissue | Facility | 2020 | 23 | 171 | $17,955 | $4,382 | 24.4% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2020 | 23 | 35 | $9,415 | $2,634 | 28.0% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2020 | 36 | 63 | $5,670 | $1,513 | 26.7% |
| 88342 | Tissue or cell analysis by immunologic technique | Facility | 2020 | 30 | 40 | $5,640 | $1,275 | 22.6% |
| 88360 | Microscopic genetic analysis of tumor | Facility | 2020 | 16 | 31 | $5,611 | $1,183 | 21.1% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2020 | 34 | 34 | $2,652 | $737.74 | 27.8% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2020 | 17 | 50 | $2,000 | $543.95 | 27.2% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2020 | 16 | 19 | $1,501 | $194.89 | 13.0% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2020 | 17 | 17 | $697.00 | $190.91 | 27.4% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2020 | 20 | 21 | $609.00 | $83.91 | 13.8% |
About Dr. Cuauhtemoc Magana, MD
Dr. Cuauhtemoc Magana, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Thousand Oaks, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2011. The National Provider Identifier (NPI) number assigned to this provider is 1982996294.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Cuauhtemoc Magana, MD has received a total of $134,872 in payments from pharmaceutical and medical device companies, with $15,786 received in 2023. These payments were reported across 24 transactions from 2 companies. The most common payment nature is "Consulting Fee" ($134,795).
As a Medicare-enrolled provider, Magana has provided services to 427 Medicare beneficiaries, totaling 892 services with total Medicare billing of $25,088. Data is available for 2 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Location Thousand Oaks, CA
- Active Since 05/04/2011
- Last Updated 03/17/2018
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1982996294
Products in Payments
- PD-L1 IHC 22C3 pharmDx (Device) $52,150
- PD-L1 IHC 22C3 (Device) $36,388
- PD-L1 IHC 28-8 PHARMDX (Device) $7,881
- OMNIS (Device) $81.25
- PD-L1 (Device) $55.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology & Clinical Pathology Doctors in Thousand Oaks
Dr. Eric Broxham, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $159,811
Dr. Regina Patricia Singson, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $146,191
Dr. Joshua Segal, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $139,320
Dr. Edward Blackman, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $127,157
Dr. Jianming Yin, Md, MD
Anatomic Pathology & Clinical Pathology — Payments: $125,577
Dr. Danielle Westfall, M.d, M.D
Anatomic Pathology & Clinical Pathology — Payments: $123,954